Momenta Pharmaceuticals Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Momenta Pharmaceuticals Inc.

An SI Board Since March 2004

Posts	SubjectMarks	Bans	Symbol
3027	64	0	MNTA

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
352	Really? I just got it a few hrs ago. You r 2 fast for me Ij:-) Going to be a bor	dr.praveen	-	12/13/2006
351	That Rodman Renshaw piece came out over a week ago. ij	IRWIN JAMES FRANKEL	-	12/13/2006
350	First Take on Day 1 of Teva and Amphastar vs. Sanofi-Aventis Provided below are	dr.praveen	-	12/13/2006
349	There goes those darn isiders again! lol $900,000 was cashed in Friday. It'	Go Market Go!	-	12/12/2006
348	From the trial: AU testified in his depo that he had "drafted" his fi	IRWIN JAMES FRANKEL	-	12/12/2006
347	SNY Sanofi-Aventis: New study shows lovenox is more effective than unfractionat	IRWIN JAMES FRANKEL	-	12/12/2006
346	07:31 CALP Caliper Life Sciences announces expanded sales of its LabChip and I	IRWIN JAMES FRANKEL	-	12/12/2006
345	Good thinking. Jon	Robohogs	-	12/12/2006
344	<i>knowing the sameness trial is still out there may keep some value of pa	Sidney Street	-	12/12/2006
343	Although the intermediate path is obviously different - i.e., knowing the samene	Robohogs	-	12/11/2006
342	Right. Only the counterclaim count of inequitable conduct was tried. There is	IRWIN JAMES FRANKEL	-	12/11/2006
341	Should there be 4 columns (or an additional timeframe), i.e., extension of pate	Robohogs	-	12/11/2006
340	>>teva will fight as hard Well I heard their patent trial counsel try the	IRWIN JAMES FRANKEL	-	12/11/2006
339	Only thing is for certain teva will fight as hard as they can and so will sandoz	rkrw	-	12/11/2006
338	<i>but I think they do have some patents they'll try to defend</i&g	Pseudo Biologist	-	12/11/2006
337	Copaxone has been around forever but I think they do have some patents to defend	rkrw	-	12/11/2006
336	The great thing about a Copaxone ANDA is that there is no patent that needs to b	IRWIN JAMES FRANKEL	-	12/11/2006
335	Maybe he should add a category, perpetuating fraud, just for you.	rkrw	-	12/11/2006
334	I think your numbers are reasonable. Only comment would be if both teva/amphasta	rkrw	-	12/11/2006
333	IJ: Nice frame of reference. I've added a couple cols to make guesses at the	fred hayes	-	12/11/2006
332	What If +1+3 ? IMHO My hunch is that MNTA is making a better characterized gene	Go Market Go!	-	12/11/2006
331	In the bottommost case on your list—TEVA gets approval and MNTA gets rejected—th	DewDiligence_on_SI	-	12/11/2006
330	MNTA's FV considering 3 hurdles ahead 1 - Aventis patent 2 - TEVA/Amphastar	IRWIN JAMES FRANKEL	-	12/11/2006
329	>># 1 I believe SNY will lose the trial. Why didn't you tell me befor	Go Market Go!	-	12/8/2006
328	If they lose here, there is then the main trial at some point later which Jim or	Robohogs	-	12/8/2006

Go to reply# or date (mm/dd/yy):